DDX46, a member of the DEAD-box (DDX) helicase family, is involved in the development of several tumors. However, the exact role of DDX46 in osteosarcoma and the underlying mechanisms in tumorigenesis remain poorly understood. Thus, in the present study, we explored the role of DDX46 in osteosarcoma and the underlying mechanisms. Our results demonstrated that the expression levels of DDX46 in both mRNA and protein were greatly elevated in human osteosarcoma tissues and cell lines. Knockdown of DDX46 obviously inhibited osteosarcoma cell proliferation and tumor growth in vivo. In addition, knockdown of DDX46 also significantly suppressed migration and invasion in osteosarcoma cells. Furthermore, knockdown of DDX46 substantially downregulated the phosphorylation levels of PI3K and Akt in SaOS2 cells. In summary, the present results have revealed that DDX46 plays an important role in osteosarcoma growth and metastasis. Knockdown of DDX46 inhibited osteosarcoma cell proliferation, migration, and invasion in vitro and tumor growth in vivo. Therefore, DDX46 may be a potential therapeutic target for the treatment of osteosarcoma.
26 July 2026 in Clinical and Experimental Medicine
The comorbidity of cardiometabolic diseases, such as hypertension and diabetes, is increasingly prevalent worldwide, particularly among middle-aged and elderly populations. The cardiometabolic index (CMI), a novel composite biomarker integrating features of dyslipidemia and abdominal obesity, has emerged as a potential indicator. However, its association with prevalent hypertension–diabetes comorbidity and its risk discrimination utility across Chinese and American populations remain insufficiently investigated. This investigation utilized data from CHARLS and NHANES, encompassing 12,261 Chinese and 1,329 American participants. Multivariable logistic regression models and restricted cubic spline (RCS) analyses were employed to evaluate the association and dose-response relationship between CMI and prevalent hypertension–diabetes comorbidity. Machine learning models were constructed to evaluate risk discrimination performance, including LightGBM, GBM, and CatBoost. Mediation analysis was further conducted to assess the potential mediating role of body mass index (BMI) in the association between CMI and the outcome. Elevated CMI was significantly associated with an increased risk of hypertension-diabetes comorbidity (CHARLS: OR = 2.16, 95% CI: 2.00–2.34; NHANES: OR = 1.99, 95% CI: 1.48–2.69). RCS analysis revealed a marked nonlinear association within the Chinese cohort (threshold effect, P-nonlinear < 0.001), contrasting with a more linear relationship in the American population (P-nonlinear = 0.764). Among the machine learning models, LightGBM and GBM demonstrated superior risk discrimination performance (CHARLS AUC = 0.841; NHANES AUC = 0.948). Mediation analysis indicated that BMI exerted a significant partial mediating effect, accounting for 32.90% and 43.32% of the total association in the Chinese and American cohorts, respectively. CMI was independently associated with prevalent hypertension–diabetes comorbidity, with notable population-specific differences in association patterns. Machine learning models incorporating CMI showed favorable risk discrimination performance. The partial mediation effect of BMI underscores the critical importance of adiposity management in mitigating cardiometabolic risk. This study provides a novel theoretical framework and methodological support for cross-population cardiometabolic health assessment.
Observational studies have suggested a link between total fatty acid levels and the development of coronary atherosclerosis. While the involvement of immune cells in the pathogenesis of this condition is well‐established, the precise causal mechanisms by which fatty acids influence immune cell function and subsequently affect coronary atherosclerosis remain unclear. To address this, we systematically assessed the causal relationships among 731 immune cell traits, circulating fatty acid levels, and coronary atherosclerosis using a two‐sample Mendelian randomization (MR) approach. Multivariable Mendelian randomization (MVMR) was further employed to investigate the potential mediating role of dendritic cells in the pathway linking fatty acids to coronary atherosclerosis. Our analysis identified significant causal associations between 30 immune cell traits and coronary atherosclerosis. Furthermore, circulating fatty acid levels were causally linked to an increased risk of coronary atherosclerosis. MVMR analysis revealed that dendritic cells, specifically the CD62L− CD86+ myeloid subset, partially mediate the causal effect of fatty acid levels on coronary atherosclerosis. This study provides genetic evidence supporting the causal roles of multiple immune cell traits and fatty acid levels in coronary atherosclerosis. Importantly, dendritic cells were identified as a key mediator in the pathway through which fatty acids influence disease risk. These findings offer new insights into the interplay between nutrition and immunity in atherosclerosis and highlight potential targets for future therapeutic and preventive strategies.